Discover Great Companies Discover Great Clients
Popularity  2027 Claim this company
No.246 Xinwu District Popularity Ranking Wuxi City Jiangsu Pr No.17 Pharmaceutical Technology No.20 Biopharmaceuticals No.25 Pharmaceutical No.44 Healthcare Technology No.48 Pharmaceutical Industrial 市级创新型中小企业 科技型中小企业 省科技型中小企业

Company Overview

  • Nature: Foreign-funded Enterprise Size: 100-499 employees Founded: 6年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Cutia Therapeutics (Wuxi) Co., Ltd.。

Development Stage

  • Honors: 市级创新型中小企业 科技型中小企业 According to algorithm
  • Salary: 62.7% of positions earn 10-20K, In 2026 vs last yeargrew by 23%.。.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 63.7%, "Computer/Network/Technology": 7.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 4.4%。
  • Recruiting: In 2026 vs 2025decreased by 62%.
  • Requirement: Education: 大专 leads with 61.5%. Experience: 不限 leads with 68.1%.
  • Region: Distributed across 7 regions, 北京: 16.5%, 杭州: 13.2%, 上海: 12.1%, 广州: 7.7%.

About the Company

Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (10 open positions)

Manage
Note: How fast is hiring at Cutia Therapeutics (Wuxi) Co., Ltd. growing? 2026: 47 openings (down 62%), 2025: 125 openings (up 247%), 2024: 36 openings (down 10%), 2023: 40 openings (up 900%), 2022: 4 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2024 — 1 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Cutia Therapeutics (Wuxi) Co., Ltd. growing? Master's recruitment over the years: 2024: 1 openings (down 10%), 2023: 2 openings (up 900%).

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2023 — same as 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Cutia Therapeutics (Wuxi) Co., Ltd. growing? Doctorate recruitment over the years: 2023: 1 openings (up 900%), 2022: 1 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Cutia Therapeutics (Wuxi) Co., Ltd.? Based on an analysis of 's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 63.7%, "Computer/Network/Technology": 7.7%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 4.4%. For reference only.

— What Are the Salaries Like? (91 records)

Manage
salary range: 6K - 50K, 62.7% of roles pay ¥10-20K
Note: salary statistics are based on 91 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Cutia Therapeutics (Wuxi) Co., Ltd.?62.7% of positions earn 10-20K, Undergraduate salary: ¥。Wuxi salary ranking top 25,销售类 average salary ¥16.0K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Cutia Therapeutics (Wuxi) Co., Ltd.? We provide: Sales, Pharmaceutical Sales Representative, 临床, Channel Manager, Dermatology, Product Supervisor, 商管, Operations, Product Manager, Regional Marketing, Academic Representative, Marketing Manager, RA, Investor Relations, Leasing Manager, Maintenance Worker, Investor Relations, Supply Chain, Regional Manager, Engineering Department. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 销售类
    64.8% of total 64.8%
  • 医疗卫生/美容保健类
    63.7% of total 63.7%
  • 经营管理类
    14.3% of total 14.3%
  • 客户服务类
    7.7% of total 7.7%

Education

  • 大专
    61.5% of total 61.5%
  • 本科
    38.5% of total 38.5%

Experience

  • 不限
    68.1% of total 68.1%
  • 1-3年
    19.8% of total 19.8%
  • 3-5年
    9.9% of total 9.9%
  • 5-10年
    2.2% of total 2.2%
View Detailed Analysis

What does Cutia Therapeutics (Wuxi) Co., Ltd. require? Who is Cutia Therapeutics (Wuxi) Co., Ltd. hiring? recruitment: 销售类占比最多占64.8%,其次是医疗卫生/美容保健类占63.7%. What education can get in at ? 大专占比最多占61.5%,其次是本科占38.5%. Work experience required at ? 不限占比最多占68.1%,其次是1-3年占19.8%. Where are the job locations at ? 北京占比最多占16.5%,其次是杭州占13.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 110,000万(元)
Legal Representative: 张乐乐
Date Established:
Credit Code: 91320214MA23HQYK7F
Registered Address: 无锡市新吴区鸿山街道鸿运南路27-2、27-4

Partners & Suppliers

科笛生物从杭州领业医药获得CU-40101(外用非那雄胺喷雾)的独家授权许可 Source
供应商 技术授权

People who follow this company also follow

Competitors (Similar Companies)

医药 生物医药 研发 临床医学
人工智能 智能系统 AI算力 数据标注
生物科技/生物工程
“Leveraging medical big data to drive precise project matching, providi”
化学制药 标准物质 国际招标 化学药品
“A global pharmaceutical company headquartered in Dublin, Ireland”
医药 药学研究 仿制药 创新药
“功能性生物蛋白产品研发商”
“致力于偏光片的研发、生产和销售,是LCD 偏光片行优秀的解决方案供应商之一”
慢病管理 慢性病服务 透析器 透析液
医药 生命科学 药物研发 医药中间体
制药/药业 中成药 化学制药 生产
医药 生命科学 生命科学研究 分子靶向药物
“Tumor individualized genetic testing enterprise”

Discover Great Companies, Discover Great Clients

无锡公司名录 无锡“Xinwu District”公司名录 无锡“医药”公司名录 无锡“生物医药”公司名录 无锡“医疗科技”公司名录 无锡“医药科技”公司名录 无锡“医药工业”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates